+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatology Market - Global Forecast to 2030- Product Image
Dermatology Market - Global Forecast to 2030- Product Image
New

Dermatology Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083182
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dermatology Market grew from USD 49.05 billion in 2024 to USD 54.03 billion in 2025. It is expected to continue growing at a CAGR of 9.68%, reaching USD 85.42 billion by 2030.

In an era defined by rapid scientific breakthroughs and evolving patient expectations, the dermatology sector stands at the threshold of unprecedented transformation. Innovations in molecular biology, digital health platforms, and emerging therapies have converged to redefine how clinicians diagnose, treat, and manage skin conditions. This executive summary delivers a concise yet comprehensive overview of the market dynamics shaping the industry today. From disruptive technologies to regulatory shifts and global trade developments, each element plays a crucial role in guiding strategic decision-making for stakeholders. By exploring the latest trends-from personalized interventions targeting acne and psoriasis to teledermatology’s rise in rural communities-this document equips industry leaders with actionable intelligence. As we navigate the complexities of patient demographics, treatment modalities, and competitive landscapes, our analysis underscores critical inflection points that demand attention. With an emphasis on clarity and depth, this introduction sets the stage for a deeper examination of transformative shifts, tariff impacts, segmentation nuances, regional highlights, and corporate strategies. Ultimately, this summary aims to empower decision-makers to chart a course toward sustainable growth and improved patient outcomes across the dermatology ecosystem.

Transformative Shifts in the Dermatology Landscape

The dermatology market has witnessed several transformative shifts that are redefining both clinical practice and commercial strategy. Artificial intelligence-powered diagnostic tools now enable earlier, more precise detection of skin cancer, while machine learning algorithms continuously refine treatment protocols for chronic conditions such as psoriasis and eczema. Additionally, teledermatology platforms have bridged access gaps, allowing specialists to consult with patients in remote regions via high-resolution imaging and secure data sharing. Personalized medicine has also gained momentum, with genetic profiling guiding targeted biologic therapies for severe inflammatory disorders. Concurrently, the industry has responded to consumer demand for sustainable, ethically sourced skincare formulations, prompting companies to adopt transparent supply chains and green chemistry principles. Furthermore, regulatory bodies are streamlining approval processes for novel treatments like gene therapies, accelerating their entry into clinical practice. These dynamics collectively signal a shift toward patient-centric, technology-driven care pathways, challenging established players to adapt swiftly or risk obsolescence. By reevaluating R&D priorities and forging strategic partnerships with tech innovators, dermatology leaders can harness these transformative forces to enhance outcomes, optimize costs, and foster long-term resilience.

Cumulative Impact of United States Tariffs 2025

The imposition of new United States tariffs beginning in 2025 has introduced both challenges and opportunities across the dermatology value chain. Increased duties on imported active pharmaceutical ingredients and medical devices have elevated production costs, compelling manufacturers to reexamine supply sources and negotiate more favorable terms with raw-material suppliers. In response, several firms have accelerated localization of key processes, establishing domestic manufacturing hubs to mitigate tariff exposure. Meanwhile, distributors and wholesalers have adjusted pricing strategies, absorbing part of the additional burden to preserve market share while passing on incremental costs to payers and end-users. Conversely, some innovators have leveraged the tariff environment to promote homegrown solutions, underscoring proprietary technologies as “Made in America” to reinforce brand differentiation. Despite near-term price pressures, these measures have catalyzed a shift toward more robust, vertically integrated operations. Importantly, stakeholders that proactively invested in supply-chain visibility tools-using blockchain and real-time analytics-have improved inventory management, reduced waste, and maintained service levels. As the tariff landscape continues to evolve, agile players will sustain competitive advantage by blending cost containment with strategic localization strategies and robust risk management frameworks.

Key Segmentation Insights

An in-depth segmentation analysis reveals the dermatology market’s multifaceted nature, illuminating pathways for targeted growth. When viewed through the lens of disorder categories, acne vulgaris stands out for its diverse treatment landscape, encompassing lifestyle interventions alongside oral medications, procedural approaches, and topical formulations. Eczema research similarly spans subtypes such as atopic, contact-divided into allergic and irritant forms-seborrheic, and stasis dermatitis, each requiring tailored management strategies. Fungal infections further diversify the portfolio, with candidiasis, onychomycosis, and tinea versicolor therapies addressing distinct pathogen profiles. Psoriasis specialists deploy biologics, light therapy, systemic agents, and topical treatments to tackle its chronic inflammatory nature. Rosacea management differentiates between erythematotelangiectatic, ocular, papulopustular, and phymatous variants, while the skin cancer segment prioritizes early detection, prevention, and interventions for basal cell, squamous cell carcinoma, and melanoma. Layered on this clinical vista is a matrix of treatment modalities, from excisional and Mohs surgery to depot medications, injectables, oral pills, cryotherapy, laser therapy, microneedling, and a broad spectrum of creams, gels, ointments, and patches. Patient demographics shape adoption patterns, with adults, geriatrics, and pediatrics presenting unique clinical considerations, alongside variations across African American, Asian, Hispanic, female, and male populations. Product types further refine market focus, spanning diagnostic and treatment devices, over-the-counter and prescription pharmaceuticals, and skincare essentials like cleansers, moisturizers, and sunscreens. End-user environments such as ambulatory surgical centers, dermatology clinics, homecare settings, and hospitals dictate channel strategies, while the emergence of biologics, gene therapies-CRISPR and RNA interference-and innovative topicals signal the next wave of therapeutic breakthroughs.

Key Regional Insights

Regional dynamics continue to exert a profound influence on dermatology market trajectories. In the Americas, healthcare systems in the United States and Canada lead in adopting cutting-edge treatments and digital platforms, supported by robust reimbursement frameworks and a strong emphasis on preventive screening programs. Latin America exhibits burgeoning interest in teledermatology, driven by a desire to address specialist shortages in rural communities. Transitioning to Europe, Middle East & Africa, the regulatory landscape varies widely: Western European nations maintain fast-track pathways for novel drugs, whereas markets in the Middle East focus on expanding access through public-private partnerships, and select African countries invest in capacity building to combat endemic skin diseases. Meanwhile, the Asia-Pacific region registers rapid growth fueled by rising disposable incomes, expanding medical infrastructure, and a cultural trend toward aesthetic dermatology. China and India emerge as pivotal hubs for both clinical trials and local manufacturing, while Southeast Asian markets display increasing demand for sun protection and anti-aging products. Across all regions, cross-border collaboration on research initiatives and harmonized standards holds promise for accelerating innovation and improving patient care globally.

Key Company Insights

The competitive landscape features a blend of established pharmaceutical giants, specialized dermatology firms, and emerging biotech players, each advancing unique strategies. AbbVie and Pfizer continue to invest heavily in biologics research, while Novartis and Roche focus on oncology-related skin cancer therapies. Johnson & Johnson and L'Oréal leverage vast consumer insights to drive skincare product innovation. Allergan and Galderma concentrate on procedural aesthetics and injectables, whereas Amgen and Sanofi explore gene therapy platforms for chronic inflammatory conditions. GlaxoSmithKline and Merck maintain strong ties to dermatology through vaccine development and novel systemic agents. Meanwhile, companies like Almirall and Leo Pharma enhance their portfolios through strategic acquisitions, and Sun Pharmaceutical and Biocon capitalize on cost-effective generics manufacturing. Emerging specialists such as DermTech and Revance differentiate via precision diagnostics and neuromodulator technologies, respectively. Eli Lilly, Valeant, and Biocon collaborate on biosimilars to broaden market access, while innovative device manufacturers expand cryotherapy, laser therapy, and microneedling offerings. This mosaic of capabilities underscores the importance of strategic alliances, licensing agreements, and targeted R&D investments to secure leadership in a rapidly evolving field.

Actionable Recommendations for Industry Leaders

To navigate this complex environment, industry leaders must embrace a series of actionable strategies. First, fostering collaborative research and development partnerships with academic institutions and technology firms will accelerate the translation of genomic discoveries into viable therapies. Second, optimizing supply-chain resilience through dual-sourcing strategies and real-time visibility platforms will mitigate tariff-induced cost pressures and ensure consistent product availability. Third, expanding teledermatology and remote-monitoring services can deepen market penetration in underserved regions while enhancing patient engagement. Fourth, investing in patient-centric data analytics will enable precision targeting of demographic segments, improving outcomes and payer reimbursement potential. Fifth, forging cross-industry alliances-spanning pharmaceutical, device, and digital health sectors-will unlock integrative care solutions that address both clinical and lifestyle needs. Lastly, committing to sustainability goals by adopting green manufacturing processes and eco-friendly packaging will resonate with consumers and satisfy emerging regulatory requirements. By implementing these measures, organizations can strengthen competitive positioning, drive innovation, and deliver value at every stage of the patient journey.

Conclusion: Charting a Path to Dermatology Excellence

In summary, the dermatology market stands at a pivotal juncture characterized by technological breakthroughs, regulatory evolution, and shifting patient expectations. The convergence of advanced diagnostics, personalized therapeutics, and digital health solutions creates fertile ground for growth-provided that industry participants adapt with speed and foresight. Tariff changes underscore the critical need for supply-chain agility, while segmentation insights reveal abundant opportunities across disorders, modalities, demographics, and end-user settings. Regional nuances demand tailored market entry and expansion strategies, and the competitive landscape calls for strategic collaborations and focused R&D investments. By aligning organizational capabilities with these dynamic forces, stakeholders can enhance clinical outcomes, expand access, and sustain profitable growth. The path forward involves a balanced approach: harnessing innovation while reinforcing operational resilience and embracing patient-centric care at its core. Ultimately, those who integrate scientific rigor with strategic adaptability will lead the next wave of dermatology excellence.

Market Segmentation & Coverage

This research report categorizes the Dermatology Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Acne Vulgaris
    • Lifestyle Interventions
    • Oral Medications
    • Procedures
    • Topical Treatments
  • Eczema
    • Atopic Dermatitis
    • Contact Dermatitis:
      • Allergic
      • Irritant
    • Seborrheic Dermatitis
    • Stasis Dermatitis
  • Fungal Infections
    • Candidiasis
    • Onychomycosis
    • Tinea Versicolor
  • Psoriasis
    • Biologics
    • Light Therapy
    • Systemic Agents
    • Topical Therapies
  • Rosacea
    • Erythematotelangiectatic
    • Ocular
    • Papulopustular
    • Phymatous
  • Skin Cancer
    • Basal Cell Carcinoma
    • Early Detection and Prevention
    • Melanoma
    • Squamous Cell Carcinoma
  • Surgical Interventions
    • Excisional Surgery
    • Mohs Surgery
  • Systemic Therapies
    • Depot Medications
    • Injectables
    • Oral Pills
  • Technological Treatments
    • Cryotherapy
    • Laser Therapy
    • Microneedling
  • Topical Agents
    • Creams
    • Gels
    • Ointments
    • Patches
  • Age Group
    • Adults
    • Geriatrics
    • Pediatrics
  • Ethnic Group
    • African American
    • Asian
    • Hispanic
  • Gender
    • Female
    • Male
  • Race
  • Medical Devices
    • Diagnostic Devices
    • Treatment Devices
  • Pharmaceuticals
    • Over-The-Counter
    • Prescription
  • Skincare Products
    • Cleansers
    • Moisturizers
    • Sunscreens
  • Ambulatory Surgical Centers
  • Dermatology Clinics
  • Homecare Settings
  • Hospitals
  • Biologics
  • Gene Therapy
    • CRISPR
    • RNA Interference
  • Innovative Topicals

This research report categorizes the Dermatology Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dermatology Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Allergan plc
  • Almirall, S.A.
  • Amgen Inc.
  • Biocon Limited
  • DermTech, Inc.
  • Eli Lilly and Company
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • L'Oréal Group
  • Leo Pharma A/S
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Revance Therapeutics, Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dermatology Market, by Disorders
8.1. Introduction
8.2. Acne Vulgaris
8.2.1. Lifestyle Interventions
8.2.2. Oral Medications
8.2.3. Procedures
8.2.4. Topical Treatments
8.3. Eczema
8.3.1. Atopic Dermatitis
8.3.2. Contact Dermatitis:
8.3.2.1. Allergic
8.3.2.2. Irritant
8.3.3. Seborrheic Dermatitis
8.3.4. Stasis Dermatitis
8.4. Fungal Infections
8.4.1. Candidiasis
8.4.2. Onychomycosis
8.4.3. Tinea Versicolor
8.5. Psoriasis
8.5.1. Biologics
8.5.2. Light Therapy
8.5.3. Systemic Agents
8.5.4. Topical Therapies
8.6. Rosacea
8.6.1. Erythematotelangiectatic
8.6.2. Ocular
8.6.3. Papulopustular
8.6.4. Phymatous
8.7. Skin Cancer
8.7.1. Basal Cell Carcinoma
8.7.2. Early Detection and Prevention
8.7.3. Melanoma
8.7.4. Squamous Cell Carcinoma
9. Dermatology Market, by Treatment Modalities
9.1. Introduction
9.2. Surgical Interventions
9.2.1. Excisional Surgery
9.2.2. Mohs Surgery
9.3. Systemic Therapies
9.3.1. Depot Medications
9.3.2. Injectables
9.3.3. Oral Pills
9.4. Technological Treatments
9.4.1. Cryotherapy
9.4.2. Laser Therapy
9.4.3. Microneedling
9.5. Topical Agents
9.5.1. Creams
9.5.2. Gels
9.5.3. Ointments
9.5.4. Patches
10. Dermatology Market, by Patient Demographics
10.1. Introduction
10.2. Age Group
10.2.1. Adults
10.2.2. Geriatrics
10.2.3. Pediatrics
10.3. Ethnic Group
10.3.1. African American
10.3.2. Asian
10.3.3. Hispanic
10.4. Gender
10.4.1. Female
10.4.2. Male
10.5. Race
11. Dermatology Market, by Product Types
11.1. Introduction
11.2. Medical Devices
11.2.1. Diagnostic Devices
11.2.2. Treatment Devices
11.3. Pharmaceuticals
11.3.1. Over-The-Counter
11.3.2. Prescription
11.4. Skincare Products
11.4.1. Cleansers
11.4.2. Moisturizers
11.4.3. Sunscreens
12. Dermatology Market, by End-Users
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Dermatology Clinics
12.4. Homecare Settings
12.5. Hospitals
13. Dermatology Market, by Emerging Therapies
13.1. Introduction
13.2. Biologics
13.3. Gene Therapy
13.3.1. CRISPR
13.3.2. RNA Interference
13.4. Innovative Topicals
14. Americas Dermatology Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Dermatology Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Dermatology Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Allergan plc
17.3.3. Almirall, S.A.
17.3.4. Amgen Inc.
17.3.5. Biocon Limited
17.3.6. DermTech, Inc.
17.3.7. Eli Lilly and Company
17.3.8. Galderma S.A.
17.3.9. GlaxoSmithKline plc
17.3.10. Johnson & Johnson
17.3.11. L'Oréal Group
17.3.12. Leo Pharma A/S
17.3.13. Merck & Co., Inc.
17.3.14. Novartis International AG
17.3.15. Pfizer Inc.
17.3.16. Revance Therapeutics, Inc.
17.3.17. Roche Holding AG
17.3.18. Sanofi S.A.
17.3.19. Sun Pharmaceutical Industries Ltd.
17.3.20. Valeant Pharmaceuticals International, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DERMATOLOGY MARKET MULTI-CURRENCY
FIGURE 2. DERMATOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. DERMATOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DERMATOLOGY MARKET SIZE, BY DISORDERS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DERMATOLOGY MARKET SIZE, BY DISORDERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DERMATOLOGY MARKET SIZE, BY END-USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DERMATOLOGY MARKET SIZE, BY END-USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DERMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DERMATOLOGY MARKET SIZE, BY LIFESTYLE INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DERMATOLOGY MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DERMATOLOGY MARKET SIZE, BY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DERMATOLOGY MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DERMATOLOGY MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DERMATOLOGY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DERMATOLOGY MARKET SIZE, BY ALLERGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DERMATOLOGY MARKET SIZE, BY IRRITANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DERMATOLOGY MARKET SIZE, BY SEBORRHEIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DERMATOLOGY MARKET SIZE, BY STASIS DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DERMATOLOGY MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DERMATOLOGY MARKET SIZE, BY ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DERMATOLOGY MARKET SIZE, BY TINEA VERSICOLOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DERMATOLOGY MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DERMATOLOGY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DERMATOLOGY MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DERMATOLOGY MARKET SIZE, BY SYSTEMIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DERMATOLOGY MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DERMATOLOGY MARKET SIZE, BY ROSACEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DERMATOLOGY MARKET SIZE, BY ERYTHEMATOTELANGIECTATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DERMATOLOGY MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DERMATOLOGY MARKET SIZE, BY PAPULOPUSTULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DERMATOLOGY MARKET SIZE, BY PHYMATOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DERMATOLOGY MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DERMATOLOGY MARKET SIZE, BY BASAL CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DERMATOLOGY MARKET SIZE, BY EARLY DETECTION AND PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DERMATOLOGY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DERMATOLOGY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DERMATOLOGY MARKET SIZE, BY EXCISIONAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DERMATOLOGY MARKET SIZE, BY MOHS SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DERMATOLOGY MARKET SIZE, BY DEPOT MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DERMATOLOGY MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DERMATOLOGY MARKET SIZE, BY ORAL PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DERMATOLOGY MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DERMATOLOGY MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DERMATOLOGY MARKET SIZE, BY MICRONEEDLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DERMATOLOGY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DERMATOLOGY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DERMATOLOGY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DERMATOLOGY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DERMATOLOGY MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DERMATOLOGY MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DERMATOLOGY MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DERMATOLOGY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DERMATOLOGY MARKET SIZE, BY AFRICAN AMERICAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DERMATOLOGY MARKET SIZE, BY ASIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DERMATOLOGY MARKET SIZE, BY HISPANIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DERMATOLOGY MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DERMATOLOGY MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DERMATOLOGY MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL DERMATOLOGY MARKET SIZE, BY RACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL DERMATOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL DERMATOLOGY MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL DERMATOLOGY MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL DERMATOLOGY MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL DERMATOLOGY MARKET SIZE, BY CLEANSERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL DERMATOLOGY MARKET SIZE, BY MOISTURIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL DERMATOLOGY MARKET SIZE, BY SUNSCREENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL DERMATOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL DERMATOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL DERMATOLOGY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL DERMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL DERMATOLOGY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL DERMATOLOGY MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL DERMATOLOGY MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL DERMATOLOGY MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL DERMATOLOGY MARKET SIZE, BY INNOVATIVE TOPICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 181. CANADA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 182. CANADA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 183. CANADA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 184. CANADA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 185. CANADA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 186. CANADA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 187. CANADA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 188. CANADA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 189. CANADA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 190. CANADA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 191. CANADA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 192. CANADA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 193. CANADA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 194. CANADA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 195. CANADA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. CANADA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 197. CANADA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 198. CANADA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 199. CANADA DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 200. CANADA DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 201. CANADA DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 202. CANADA DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 203. CANADA DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 204. CANADA DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 205. MEXICO DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 206. MEXICO DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 208. MEXICO DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 209. MEXICO DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 212. MEXICO DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 213. MEXICO DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 214. MEXICO DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 216. MEXICO DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 217. MEXICO DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 219. MEXICO DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. MEXICO DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 221. MEXICO DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 222. MEXICO DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 223. MEXICO DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 224. MEXICO DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 225. MEXICO DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 226. MEXICO DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 227. MEXICO DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 228. MEXICO DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 303. CHINA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 304. CHINA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 305. CHINA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 306. CHINA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 307. CHINA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 308. CHINA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 309. CHINA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 310. CHINA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 311. CHINA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 312. CHINA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 313. CHINA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 314. CHINA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 315. CHINA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 316. CHINA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 317. CHINA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 318. CHINA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 319. CHINA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 320. CHINA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 321. CHINA DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 322. CHINA DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 323. CHINA DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 324. CHINA DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 325. CHINA DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 326. CHINA DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 327. INDIA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 328. INDIA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 329. INDIA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 330. INDIA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 331. INDIA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 332. INDIA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 333. INDIA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 334. INDIA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 335. INDIA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 336. INDIA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 337. INDIA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 338. INDIA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 339. INDIA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 340. INDIA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 341. INDIA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 342. INDIA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 343. INDIA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 344. INDIA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 345. INDIA DERMATOLOGY MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 346. INDIA DERMATOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 347. INDIA DERMATOLOGY MARKET SIZE, BY SKINCARE PRODUCTS, 2018-2030 (USD MILLION)
TABLE 348. INDIA DERMATOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 349. INDIA DERMATOLOGY MARKET SIZE, BY EMERGING THERAPIES, 2018-2030 (USD MILLION)
TABLE 350. INDIA DERMATOLOGY MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA DERMATOLOGY MARKET SIZE, BY DISORDERS, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA DERMATOLOGY MARKET SIZE, BY ACNE VULGARIS, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA DERMATOLOGY MARKET SIZE, BY ECZEMA, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA DERMATOLOGY MARKET SIZE, BY CONTACT DERMATITIS:, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA DERMATOLOGY MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA DERMATOLOGY MARKET SIZE, BY PSORIASIS, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA DERMATOLOGY MARKET SIZE, BY ROSACEA, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA DERMATOLOGY MARKET SIZE, BY SKIN CANCER, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITIES, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA DERMATOLOGY MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
TABLE 361. INDONESIA DERMATOLOGY MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 362. INDONESIA DERMATOLOGY MARKET SIZE, BY TECHNOLOGICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 363. INDONESIA DERMATOLOGY MARKET SIZE, BY TOPICAL AGENTS, 2018-2030 (USD MILLION)
TABLE 364. INDONESIA DERMATOLOGY MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 365. INDONESIA DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 366. INDONESIA DERMATOLOGY MARKET SIZE, BY ETHNIC GROUP, 2018-2030 (USD MILLION)
TABLE 367. INDONESIA DERMATOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 368. INDONESIA DERMATOLOGY MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 369. INDONESIA DERMATOLOGY MARKE

Companies Mentioned

  • AbbVie Inc.
  • Allergan plc
  • Almirall, S.A.
  • Amgen Inc.
  • Biocon Limited
  • DermTech, Inc.
  • Eli Lilly and Company
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • L'Oréal Group
  • Leo Pharma A/S
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Revance Therapeutics, Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dermatology Devices Market - Global Forecast to 2030 - Product Image

Dermatology Devices Market - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global, United States Global, United States
From
Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 247 Pages
  • Global
From
Dermatology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Dermatology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Dermatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dermatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.